• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Winton European Equity Fnd Z GBP Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Winton Capital Management Ltd.
Fund Summary The investment objective of the Fund is to seek to achieve long term investment growth with a view to outperforming the MSCI Europe Net Total Return Index (the Index) over a 5 year investment period.
SEDOL code BYWTZ63
ISIN IE00BYWTZ635
Fund code WNEEI
Managers David Harding
Manager Tenure 5 years
Morningstar Category Europe Large-Cap Blend Equity
IMA Sector Europe Including UK
Fund Size £49 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.18%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £103.7900
Buy Price £103.7900
Price Change -0.2201%
Price Date 18th November 2019
Yield Currently unavailable
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 28th August 2018
Fund Status OPEN
David Harding is the Founder and CEO of Winton. Since graduating from Cambridge University with a degree in natural sciences, he has started two of the world's leading quantitative investment companies: AHL and Winton. Founded in 1997, Winton is a global investment manager specialising in the application of scientific methods to financial markets. David’s philanthropy focuses on promoting scientific research and science education. His notable endowments include the Winton Chair for the Public Understanding of Risk at Cambridge University, the Winton Programme for the Physics of Sustainability at the Cavendish Laboratory, the Harding Centre for Risk Literacy at the Max Planck Institute in Berlin and the Maths Gallery at the Science Museum in London. He is an honorary fellow of the Science Museum and St Catherine’s College in Cambridge.

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017
Fund Performance -1.50% +2.38%
Benchmark Performance
(Europe Large-Cap Blend Equity)
+1.53% +1.77%
Time Period Cumulative Benchmark Performance
(Europe Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day 0.62% +17.17% -16.54%
1 week -0.46% +2.62% -3.08%
1 month 2.28% +2.83% -0.55%
3 months 2.75% +4.36% -1.61%
6 months 6.50% +10.68% -4.18%
1 year 7.23% +2.33% +4.90%
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 16.25% -0.04% +16.29%
Since inception 1.68% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Roche Holding AG Dividend Right Cert. CHE 1.15%
Novartis AG CHE 1.01%
Allianz SE DEU 0.78%
Royal Dutch Shell PLC B GBR 0.76%
Koninklijke Ahold Delhaize NV USA 0.75%
GlaxoSmithKline PLC GBR 0.72%
HSBC Holdings PLC GBR 0.69%
Diageo PLC GBR 0.69%
Etablissementen Franz Colruyt NV BEL 0.67%
Heineken Holding NV NLD 0.66%

Currently unavailable